Vanda Pharmaceuticals Settles HETLIOZĀ® Patent Litigation with MSN

Go back to Vanda Pharmaceuticals Settles HETLIOZĀ® Patent Litigation with MSN
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Delayed: 5.44 +0.11 (2.06%)
Previous Close $5.33    52 Week High $18.00 
Open $5.34    52 Week Low $6.91 
Day High $5.50    P/E N/A 
Day Low $5.34    EPS $-0.67 
Volume 876,347